Anvisa interrompe estudos com a Coronavac alegando “evento adverso grave”
A Agência Nacional de Vigilância Sanitária (Anvisa) determinou a interrupção do estudo clínico da vacina Coronavac após o registro de ...
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.